Screener
Sana Biotechnology SANA Investing Cash Flow
Investing Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Sana Biotechnology in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.
The source filing: Sana Biotechnology’s 10-Q, filed May 11, 2026.
- Filed
- May 11, 2026, 4:10 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-216769
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Proceeds from maturities of marketable securities | 55,065 | 18,168 |
| Purchases of property and equipment | (288) | (136) |
| Proceeds from disposal of assets | 248 | 253 |
| Net cash provided by investing activities | 49,437 | 16,603 |
| FINANCING ACTIVITIES: | ||
| Proceeds from employee stock purchase plan and exercise of stock options | 59 | 1,127 |
| Fees related to common stock financings, net | (96) | (60) |
| Principal payments, net for tenant improvement loan | (91) | (85) |
Item 1. Financial Statements
FAQ
- What is Sana Biotechnology's investing cash flow?
- Sana Biotechnology (SANA) reported investing cash flow of $49.44M in Q1 2026.
- How has Sana Biotechnology's investing cash flow changed year-over-year?
- Sana Biotechnology's investing cash flow increased by 197.8% year-over-year, from $16.6M to $49.44M.
- What is the long-term trend for Sana Biotechnology's investing cash flow?
- Over 3 years (2021 to 2025), Sana Biotechnology's investing cash flow has grown at a -45.3% compound annual growth rate (CAGR), from -$245.8M to -$40.24M.
- What does investing cash flow mean?
- Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.
Ask your AI about Sana Biotechnology's investing cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude